- Abstract:
-
Treatment of tumors with ionizing radiation stimulates an antitumor immune response partly dependent on induction of IFNs. These IFNs directly enhance dendritic cell and CD8+ T cell activity. Here we show that resistance to an effective antitumor immune response is also a result of IFN signaling in a different cellular compartment of the tumor, the cancer cells themselves. We abolished type I IFN signaling in cancer cells by genetic elimination of its receptor, IFNAR1. Pronounced immune respo...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Publisher:
- American Society for Clinical Investigation Publisher's website
- Journal:
- Journal of Clinical Investigation Journal website
- Volume:
- 129
- Issue:
- 10
- Pages:
- 4224-4238
- Publication date:
- 2019-10-01
- Acceptance date:
- 2019-07-03
- DOI:
- EISSN:
-
1558-8238
- ISSN:
-
0021-9738
- Pmid:
-
31483286
- Pubs id:
-
1049655
- Local pid:
- pubs:1049655
- Language:
- English
- Keywords:
- Format:
- Copyright holder:
- Chen et al.
- Copyright date:
- 2019
- Rights statement:
- © 2019 Chen, et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
- License:
- CC Attribution (CC BY)
Journal article
Type I IFN protects cancer cells from CD8+ T cell-mediated cytotoxicity after radiation
Actions
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record